The impact of patient characteristics on long-term results of above-knee prosthetic femoropopliteal bypass for critical ischemia

International Angiology

Volumn 24, Issue 4, 2005, Pages 349-354

  Pedersen, Gustav ^a,b   Laxdal, E ^a,b   Hagala, M ^a   Amundsen, S R ^a   Dregelid, E ^a   Aune, S ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Femoral artery; Ischemia; Knee; Leg; Popliteal artery; Prosthesis

Indexed keywords

ABOVE KNEE PROSTHESIS; ADULT; AGED; ARTICLE; COMORBIDITY; CRITICAL ILLNESS; DACRON VASCULAR PROSTHESIS; FEMALE; FEMOROPOPLITEAL BYPASS; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN CHARACTERISTIC; LEG ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT INFORMATION; POLITEF IMPLANT; POSTOPERATIVE PERIOD; RISK FACTOR; SMOKING; SURVIVAL RATE; TISSUE INJURY; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR PATENCY;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; POPLITEAL ARTERY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 30844471988     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Burger DH, Kappetein AP, van Bockel JH, Breslau PJ. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. J Vasc Surg 2000;32:278-83.
2. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004;27:357-62.
3. Second European Consensus Document on chronic critical leg ischaemia. Eur J Vasc Endovasc Surg 1992;6: 1-32.
4. Statistics Norway. Mortality rates, by sex and age. http://www.ssb.no/english/yearbook/tab/t-020210-075.html. 2002.
5. Laxdal E, Jenssen GL, Pedersen G, Aune S. Subintimal angioplasty as a treatment of femoropopliteal artery occlusions. Eur J Vasc Endovasc Surg 2003;25:578-82.
6. Wolfe JH, Wyatt MG. Critical and subcritical ischemia. Eur J Vasc Endovasc Surg 1997;13:578-82.
7. Post S, Kraus T, Muller-Reinartz U, Weiss C, Kortmann H, Quentmeier A et al. Dacron vs polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg 2001;22:226-31.
8. Korn P, Hoenig SJ, Skillman JJ, Kent KC. Is lower extremity revascularization worthwhile in patients with endstage renal disease? Surgery 2000;128:472-9.
9. Baele HR, Piotrowski JJ, Yuhas J, Anderson C, Alexander JJ. Infrainguinal bypass in patients with end-stage renal disease. Surgery 1995;117:319-24.
10. Calle-Pascual AL, Duran A, Diaz A, Monux G, Serrano FJ, de la Torre NG et al. Comparison of peripheral arterial reconstruction in diabetic and non-diabetic patients: a prospective clinic-based study. Diabetes Res Clin Pract 2001;53:129-36.
11. Adam DJ, Stonebridge PA, Belch JJ, Murie JA. Antiplatelet and anticoagulant therapy to prevent bypass graft thrombosis in patients with lower extremity arterial occlusive disease. Int Angiol 2001;20:90-8.
12. Miyazaki K, Nishibe T, Sata F, Miyazaki YI, Kudo FA, Flores J et al. Prosthetic grafts for above-knee femoropopliteal bypass. A multicenter retrospective study of 564 grafts. Int Angiol 2002;21:145-51.
13. Robinson BI, Fletcher JP, Tomlinson P, Allen RD, Hazelton SJ, Richardson AJ et al. A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypass. Cardiovasc Surg 1999;7:214-8.
14. Abbott WM, Green RM, Matsumoto T, Wheeler JR, Miller N, Veith FJ et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. J Vasc Surg 1997;25:19-28.
15. Evans LE, Webster MW, Brooks DH, Bahnson HT. Expanded polytetrafluoroethylene femoropopliteal grafts: forty-eight-month follow-up. Surgery 1981;89:16-22.
16. Prendiville EJ, Yeager A, O'Donnell TF Jr, Coleman JC, Jaworek A, Callow AD et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J Vasc Surg 1990;11:517-24.
17. Ameli FM, Stein M, Provan JL, Prosser R. The effect of postoperative smoking on femoropopliteal bypass grafts. Ann Vasc Surg 1989;3:20-5.
18. Wiseman S, Powell J, Greenhalgh R, McCollum C, Kenchington G, Alexander C et al. The influence of smoking and plasma factors on prosthetic graft patency. Eur J Vasc Surg 1990;4:57-61.